Lying awake at 3 a.m. turns out to be more than a miserable night – it may be quietly reshaping your brain. A 2025 study tracked over 2,700 cognitively healthy older adults for more than five years and found something striking in their brain scans: the people struggling with chronic sleep problems showed physical changes in brain tissue that the others did not. The cognitive gap between those two groups, measured by annual memory and thinking tests, was equivalent to four years of additional aging.
That number comes from the Mayo Clinic Study of Aging, one of the longest-running efforts to understand how everyday habits shape brain health in older adults. The researchers weren’t just asking whether poor sleepers scored worse on memory tests. They were looking inside the brain with imaging technology, tracing the accumulation of toxic proteins and damage to the brain’s internal wiring – the kind of changes that precede dementia by years. What they found has added new urgency to a conversation most adults over 50 have been quietly avoiding.
The nightly habit at issue is insomnia: specifically, chronic insomnia, defined as trouble falling or staying asleep at least three nights a week for three months or more. It’s not occasional wakefulness or a few rough nights after a stressful week. It’s persistent, recurring poor sleep – and it’s far more common than most people realize, affecting nearly one in three older adults in the U.S. The new science on what it does to the brain, and what can actually be done about it, is worth understanding in detail.
1. Chronic Insomnia Raises Your Dementia Risk by 40%
A study published in the September 2025 issue of Neurology, the medical journal of the American Academy of Neurology, found that people with chronic insomnia had a 40% higher risk of developing mild cognitive impairment or dementia than those without insomnia – the equivalent of 3.5 additional years of aging.
For the study, researchers recruited 2,750 adults with an average age of 70 who were cognitively healthy at the start. Participants were tracked for an average of 5.6 years, taking annual thinking and memory tests and undergoing brain scans to look for white matter hyperintensities and beta-amyloid plaques – a hallmark of Alzheimer’s disease.
During the study, 14% of people with chronic insomnia developed mild cognitive impairment or dementia, compared to 10% of those without insomnia. After accounting for factors like age, high blood pressure, sleep medication use, and sleep apnea, people with insomnia were still 40% more likely to develop cognitive impairment or dementia. The study is observational, which means it shows a strong association rather than direct cause and effect – but the size of the cohort, the length of follow-up, and the consistency of findings across multiple brain imaging measures make the signal difficult to dismiss.
The practical threshold matters here. Chronic insomnia is defined as trouble sleeping at least three days a week for three months or more. If that description sounds familiar, you’re not dealing with ordinary tiredness – you may be in a category that warrants a real conversation with your doctor.
2. The Effect on Cognition Mirrors Being Four Years Older
The 40% increased dementia risk is a lifetime figure measured across nearly six years of follow-up. What the study also captured was a more immediate measure of cognitive aging: how quickly thinking skills declined over the course of the study, independent of any dementia diagnosis.
Participants reporting reduced sleep showed cognitive declines comparable to being four years older. To put that in context, four years of brain aging is roughly the cognitive gap between a 68-year-old and a 72-year-old. For someone who goes to bed every night struggling to sleep, those years are compressing. The brain is aging faster than the calendar says it should be.
Dr. Diego Carvalho, a sleep medicine specialist at Mayo Clinic in Rochester, Minnesota, and lead researcher on the study, described the findings as suggesting chronic insomnia “could be an early warning sign or even a contributor to future cognitive problems,” adding that treating chronic insomnia may be important “not just to improve sleep quality but potentially to protect brain health as we age.”
The implications are especially relevant for people who carry the APOE4 gene variant, which raises Alzheimer’s risk. Brain scans in the study showed changes linked to Alzheimer’s, and those with genetic risk factors experienced even steeper cognitive drops. Poor sleep may interact with genetic vulnerability to accelerate decline more sharply than either factor alone.
3. Your Brain Uses Sleep to Flush Out Alzheimer’s Proteins
The glymphatic system is a brain-wide network of perivascular pathways – channels running alongside blood vessels – through which cerebrospinal fluid and interstitial fluid exchange, supporting the clearance of interstitial solutes from the brain into the blood. In plain terms: it’s the brain’s waste-removal system, and it depends heavily on sleep to operate.
A 2026 study published in Nature Communications found that sleep-active physiological processes enhance overnight glymphatic clearance of Alzheimer’s disease biomarkers into plasma in humans, supporting the critical role of glymphatic function in Alzheimer’s pathophysiology. In a randomized crossover trial with 39 participants, researchers found that glymphatic clearance during normal sleep increased morning plasma levels of Alzheimer’s biomarkers compared to sleep deprivation – evidence that the brain was actively moving these proteins out of brain tissue and into the bloodstream during sleep, exactly as animal studies had long predicted.
Glymphatic transport appears most active during non-rapid eye movement sleep, particularly during slow-wave activity, when interstitial space expands and cerebrospinal fluid exchange increases. Sleep disruption, aging, and vascular dysfunction impair this process and may accelerate Alzheimer’s-related pathology. Chronic insomnia fragments this slow-wave phase most severely, which may explain why long-term poor sleepers accumulate more of the amyloid plaques the study’s brain scans detected.
4. Insomnia Leaves Visible Damage on Brain Scans
The Mayo Clinic study didn’t just rely on cognitive tests. Researchers scanned participants’ brains for white matter hyperintensities – bright spots visible on MRI that signal damage to the brain’s internal wiring system.
White matter is the tissue that connects different regions of the brain, carrying signals between them the way cables connect devices in a network. When it’s damaged, those signals slow down, misfire, or stop entirely. White matter hyperintensities proliferate as the brain ages and are associated with increased risk for cognitive decline as well as Alzheimer’s disease and related dementias.
The connection between chronic poor sleep and white matter damage reflects a specific biological pathway. The American Academy of Neurology’s announcement on the study noted that the 40% higher risk of developing mild cognitive impairment or dementia among people with chronic insomnia was equivalent to 3.5 additional years of aging – and the white matter changes on imaging were part of the evidence supporting that acceleration.
A 2020 analysis published in Neuroscience and Biobehavioral Reviews pooling data from 36 prospective studies found that white matter hyperintensity burden at baseline conferred a 14% elevated risk of cognitive impairment and all-cause dementia. The brain damage that chronic insomnia contributes to is not hypothetical – it shows up on scans, and it carries measurable consequences.
5. Nearly Half a Million Dementia Cases May Be Preventable
The scale of the problem in the U.S. becomes striking when the data is applied to the population. According to the National Council on Aging, up to 50% of adults 60 or over report experiencing insomnia symptoms at some point. Among those aged 65 and older, the numbers are more specific: data from a 2025 government study found that 28.7% of older U.S. adults reported sleep-onset insomnia, sleep-maintenance insomnia, or both.
That same research estimated that approximately 13% of probable dementia cases among U.S. older adults could be attributable to insomnia – equivalent to roughly 471,000 potentially preventable cases in 2022 alone. These figures align with the broader landscape of dementia prevention. The 2024 Lancet Commission on dementia prevention identified 14 modifiable risk factors that could reduce dementia cases worldwide by 45% if eliminated – with sleep disorders increasingly recognized among the most actionable.
Sleep is rarely framed in the same conversation as blood pressure, cholesterol, or smoking when it comes to dementia prevention. The data increasingly suggests it belongs there.
6. The First-Line Treatment Most People Have Never Tried – and the Dementia Risk Nightly Habit to Avoid
When most people can’t sleep, they reach for a pill. The evidence points firmly in a different direction. Cognitive behavioral therapy for insomnia, known as CBT-I, is the first-line treatment for chronic and severe insomnia, endorsed by the American College of Physicians, the American Academy of Sleep Medicine, the British Association for Psychopharmacology, and backed by the National Institutes of Health Consensus Statement.
CBT-I is equally effective as medication in the short term and superior to it in the long-term management of insomnia. Unlike sleeping pills, which can mask symptoms without addressing the underlying patterns that sustain insomnia, CBT-I works by targeting the thoughts and behaviors that keep people locked in poor sleep cycles. It typically runs six to eight sessions with a trained therapist and includes techniques like sleep restriction, stimulus control, and cognitive restructuring.
Access to in-person CBT-I remains limited due to a shortage of trained providers and structural barriers, but digital CBT-I offers a scalable solution to bridge this treatment gap. Several digital platforms now deliver evidence-based CBT-I programs that have shown measurable improvements in insomnia severity in randomized controlled trials. If chronic insomnia has been a fixture of your nights for three months or more, asking your doctor specifically about CBT-I – not a sleep aid prescription – is the most evidence-supported next step.
For people concerned about both sleep and brain health, one related risk factor is worth knowing: common over-the-counter sleep aids containing diphenhydramine carry their own dementia-related concerns, a subject covered in depth at The Hearty Soul.
Read More: 3 Sleep Habits Quietly Accelerating Brain Aging, Per New Study
What This Means for You
The numbers are concrete: chronic insomnia is associated with a 40% higher risk of developing mild cognitive impairment or dementia – the equivalent of 3.5 additional years of brain aging. That risk is not inevitable, and it’s not locked in. The most actionable thing this research delivers is a clear definition of the problem: if you’re losing sleep at least three nights a week, every week, for three months or more, that’s not a personality quirk or a stress response to work through on your own. It’s a clinical condition with a recognized, effective treatment.
The brain changes documented in this study – the white matter damage, the amyloid accumulation, the accelerating cognitive test scores – develop slowly, over years, driven by the cumulative toll of fragmented, insufficient sleep. The biology of sleep is one of the few levers in dementia prevention that is both modifiable and accessible. As Dr. Carvalho noted, treating chronic insomnia matters “not just to improve sleep quality but potentially to protect brain health as we age.” Ask your doctor about CBT-I, get assessed for sleep apnea if you snore or wake unrefreshed, and take chronic insomnia as seriously as you would any other documented dementia risk factor. The evidence now warrants it.
Disclaimer: This information is not intended to be a substitute for professional medical advice, diagnosis, or treatment and is for information only. Always seek the advice of your physician or another qualified health provider with any questions about your medical condition and/or current medication. Do not disregard professional medical advice or delay seeking advice or treatment because of something you have read here.
AI Disclaimer: This article was created with the assistance of AI tools and reviewed by a human editor.
